{"gene":"APP","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2003,"finding":"Neuronal activity modulates formation and secretion of Aβ peptides from APP in hippocampal slice neurons; in turn, Aβ selectively depresses excitatory synaptic transmission in an NMDA receptor-dependent manner, suggesting activity-dependent Aβ production participates in a negative feedback on neuronal hyperactivity.","method":"Hippocampal slice electrophysiology with APP overexpression, pharmacological blockade of NMDA receptors","journal":"Neuron","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional electrophysiological readout in slice neurons with pharmacological dissection, single lab","pmids":["12670422"],"is_preprint":false},{"year":2003,"finding":"ADAM9, ADAM10, and ADAM17 each catalyze alpha-secretase cleavage of APP; dsRNA knockdown of each individually in human glioblastoma A172 cells reduced endogenous alpha-secretase activity, indicating these ADAMs collectively constitute the endogenous alpha-secretase.","method":"Overexpression in COS-7 cells measuring constitutive and regulated alpha-secretase activity; dsRNA knockdown in A172 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal approaches (OE and RNAi), single lab","pmids":["12535668"],"is_preprint":false},{"year":2001,"finding":"APP and FE65 colocalize with actin and Mena in lamellipodia and concentrate with β1-integrin in focal complexes; overexpression of APP accelerates cell migration, and co-expression of FE65 dramatically enhances this effect, likely by regulating APP surface levels.","method":"Co-localization by immunofluorescence; MDCK wound-healing migration assay; co-expression studies","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence (migration assay), single lab, two methods","pmids":["11425871"],"is_preprint":false},{"year":2008,"finding":"TAG1 acts as an extracellular functional ligand of APP; TAG1-APP interaction triggers γ-secretase-dependent AICD release and Fe65-dependent signaling, negatively modulating neurogenesis. Genetic epistasis in TAG1−/−, APP−/−, and Fe65−/− mice confirmed the TAG1→APP→Fe65 pathway order.","method":"Co-immunoprecipitation, genetic epistasis using knockout mice, rescue with AICD or AICD Fe65-binding mutant in neural precursor cells","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction data, genetic epistasis across multiple KO lines, functional rescue with domain mutant","pmids":["18278038"],"is_preprint":false},{"year":2019,"finding":"Lysosomal dysfunction in Down syndrome requires the extra APP gene copy and is specifically mediated by elevated APP-βCTF (C99); APP-βCTF raises lysosomal pH (~0.6 units), inactivating cathepsin D and other hydrolases. BACE1 inhibition or siRNA knockdown of APP reversed these deficits.","method":"Primary DS fibroblasts and Ts2 mouse neurons; direct lysosomal pH measurement; siRNA knockdown of APP; BACE1 inhibitor treatment; in vivo Bace1 allele deletion in Ts2 mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (pH measurement, siRNA, pharmacological inhibition, in vivo genetics), replicated across cell and mouse models","pmids":["31043483"],"is_preprint":false},{"year":2005,"finding":"BRI2 physically interacts with APP via their transmembrane domains (APP residues 648–719; BRI2 residues 46–106); this interaction is cis (same membrane) and increases cellular APP levels and β-secretase CTFs while decreasing α-secretase CTFs and Aβ secretion.","method":"Co-immunoprecipitation in transfected and non-transfected cells; deletion mutagenesis to map interaction domains; measurement of APP processing products","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with deletion mapping and functional processing readout, single lab","pmids":["16027166"],"is_preprint":false},{"year":1998,"finding":"hnRNP C binds a 29-nt element in the 3'-UTR of APP mRNA and stabilizes it; supplementing a reticulocyte lysate translation system with exogenous hnRNP C stabilized wild-type APP mRNA and increased APP protein synthesis ~6-fold, while mRNAs lacking the 29-nt element were unaffected.","method":"In vitro rabbit reticulocyte lysate translation; RNA gel mobility shift assays; mutant APP mRNA lacking 29-nt element","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with cis-element mutagenesis, single lab","pmids":["9649628"],"is_preprint":false},{"year":2003,"finding":"APP-BP1 binds the C-terminal 31 amino acids (C31) of APP and colocalizes with APP in lipid rafts; coexpression of the APP-BP1 domain that binds APP abolishes APP-induced neuronal apoptosis and aberrant DNA synthesis, and a dominant-negative NEDD8-conjugating enzyme hUbc12 similarly blocks neuronal apoptosis caused by APP.","method":"Co-immunoprecipitation; lipid raft fractionation; dominant-negative hUbc12 overexpression; neuronal apoptosis assay","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding mapping, subcellular fractionation, and functional rescue by dominant-negative, single lab","pmids":["14557245"],"is_preprint":false},{"year":2011,"finding":"APP knockout reduces dendritic spine density (~35% in culture, ~15% in vivo in 12–15-month mice) and dendritic arborization in hippocampal neurons, and impairs long-term potentiation; addition of sAPPα-conditioned medium partially restores spine density, indicating sAPPα mediates APP's trophic role at synapses.","method":"APP knockout mouse; primary hippocampal neuron culture; in vivo spine counting in CA1; LTP electrophysiology; sAPPα rescue experiment","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with multiple phenotypic readouts and ligand rescue, single lab","pmids":["22884903"],"is_preprint":false},{"year":2011,"finding":"APP is phosphorylated at Y682 by TrkA upon NGF stimulation; APP physically interacts with TrkA in a Y682-dependent manner, and APP/Y682 in turn regulates activation of the NGF/TrkA signaling pathway in vivo, the subcellular distribution of TrkA, and neuronal sensitivity to NGF.","method":"Co-immunoprecipitation; phosphospecific antibodies; in vivo analysis in Y682 knock-in mice; neurotrophic survival assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, in vivo genetic model with Y682 mutation, single lab","pmids":["21849536"],"is_preprint":false},{"year":2014,"finding":"HuD RNA-binding protein binds the 3'-UTRs of APP and BACE1 mRNAs and increases their half-lives; HuD-overexpressing mice show elevated APP, BACE1, and Aβ levels in brain, establishing HuD as a post-transcriptional regulator of APP expression.","method":"RNA immunoprecipitation (RIP); mRNA half-life measurement; HuD-overexpressing transgenic mice; quantification of APP, BACE1, Aβ levels","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP with mRNA stability assay and in vivo validation in transgenic mice, single lab","pmids":["24857657"],"is_preprint":false},{"year":2007,"finding":"Phosphomimicking Tyr687 (Y687E) prevents APP endocytosis and dramatically reduces Aβ production, whereas dephosphomimicking (Y687F) preserves endocytosis and favors β-secretase cleavage, demonstrating that Tyr687 phosphorylation status determines APP subcellular targeting and processing pathway.","method":"APP-GFP fusion phosphomutants (Y687E and Y687F); live cell imaging; transferrin co-localization; Aβ ELISA","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis with functional processing readout and localization data, single lab","pmids":["17873282"],"is_preprint":false},{"year":2009,"finding":"PKC-mediated phosphorylation of APP at S655 positively modulates APP secretory traffic; phosphomimicking S655 mutants exhibit enhanced Golgi vesicular exit and increased secretory (alpha-secretase) cleavage to sAPP compared to dephosphomimicking mutants.","method":"APP695-GFP S655 phosphomutants; Golgi dynamics imaging; sAPP secretion quantification","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis with trafficking and processing readout, single lab","pmids":["19381782"],"is_preprint":false},{"year":2006,"finding":"PAT1a binds APP, APLP1, and APLP2 intracellular domains in vivo and co-localizes with them in trans-Golgi network vesicles/endosomes in primary neurons; PAT1a directly interacts with the basolateral sorting signal of APP/APLPs and its overexpression or RNAi knockdown modulates APP cell-surface levels and processing, altering Aβ secretion.","method":"Co-immunoprecipitation in vivo; co-localization in primary neurons; RNAi knockdown and overexpression; cell-surface APP quantification; Aβ ELISA","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, bidirectional perturbation (OE+KD) with functional readout, single lab","pmids":["17050537"],"is_preprint":false},{"year":2011,"finding":"Retromer deficiency (Vps35 knockdown) increases the ratio of secreted Aβ42:Aβ40 and elevates APP C-terminal fragments in exosomes, indicating that retromer-mediated retrograde transport limits amyloidogenic APP processing in late endosomes.","method":"siRNA knockdown of Vps35 in HEK-293/APP695 cells; Aβ ELISA; exosome isolation and Western blotting","journal":"Neurobiology of disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single-gene knockdown with processing readout, single lab, single method per endpoint","pmids":["21515373"],"is_preprint":false},{"year":2015,"finding":"AICD binds the Wasf1 (WAVE1) promoter and negatively regulates WAVE1 transcription; WAVE1 interacts and colocalizes with APP in the Golgi apparatus and promotes APP-containing vesicle budding and cell-surface APP levels; reducing WAVE1 decreased Aβ production and restored memory deficits in AD mice.","method":"Chromatin immunoprecipitation (AICD at Wasf1 promoter); co-immunoprecipitation (WAVE1–APP); vesicle budding assay; Aβ ELISA; in vivo Wasf1 genetic reduction in AD mouse model; behavioral testing","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, co-IP, functional vesicle assay, in vivo genetic rescue with behavioral readout, multiple orthogonal methods in single study","pmids":["26280122"],"is_preprint":false},{"year":2014,"finding":"DISC1 interacts directly with APP and regulates its surface expression and internalization; DISC1 knockdown increases cell-surface APP, reduces APP internalization, and shifts processing toward alpha-cleavage (elevated sAPPα/APP-CTFα, decreased Aβ); rescue required wild-type DISC1 but not a DISC1 mutant lacking the APP-binding domain.","method":"RNAi knockdown in primary cortical neurons; co-immunoprecipitation; cell-surface biotinylation; Western blot; Aβ ELISA","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain-deletion mutant rescue and bidirectional functional readout, single lab","pmids":["25224257"],"is_preprint":false},{"year":2011,"finding":"APP dimer formation is initiated in the endoplasmic reticulum via intermolecular disulfide bonds between cysteines in the extracellular E1 domain; APP isoforms containing the KPI domain show strongly reduced cis-dimerization; dimers formed in the ER remain stably associated at the cell surface.","method":"Organelle-retention APP constructs (KKAA-ER, KKFF-Golgi) in CHO-K1 cells; non-reducing SDS-PAGE; E1 domain deletion mutants; split-GFP; cell aggregation assay","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with mutagenesis (domain deletion) and complementary split-GFP, single lab","pmids":["22105709"],"is_preprint":false},{"year":2015,"finding":"Synaptotagmins (Syt-1, -2, -9) interact with APP in mouse brains in vivo via the 108-amino-acid linker region between E1 and KPI domains; stable overexpression of Syt-1 or Syt-9 increases APP-CTF, sAPP, and Aβ ~2–3-fold, while Syt-1 knockdown reduces Aβ40/42 and sAPPβ, indicating Syt-1 regulates Aβ generation by modulating BACE1-mediated APP cleavage.","method":"Affinity purification-coupled mass spectrometry from mouse brains; co-IP in cells and in vivo; GST pull-down domain mapping; stable OE and lentiviral KD; Aβ ELISA","journal":"Molecular neurodegeneration","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo co-IP, domain mapping, bidirectional perturbation with processing readout, single lab","pmids":["26202512"],"is_preprint":false},{"year":2016,"finding":"Palmitoylated APP (palAPP) forms dimers preferentially (~90% vs ~20% of total APP); palAPP dimers are predominantly cis-oriented and favor BACE1-mediated β-cleavage over total APP in lipid-rich detergent-resistant membranes; enzymes DHHC7 and DHHC21 increase both palmitoylation and APP dimerization, and pharmacological inhibition of palmitoylation reduces APP dimerization.","method":"FLIM/FRET and co-immunoprecipitation for dimerization; DHHC7/DHHC21 overexpression; palmitoylation inhibitors; in vitro BACE1 activity assay with isolated palAPP vs total APP","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro BACE1 activity assay with purified substrates + FRET dimerization + mutagenesis-like pharmacological inhibition, single lab","pmids":["27875558"],"is_preprint":false},{"year":2014,"finding":"Multimerization of APP CTFβ (C99) significantly impedes γ-secretase cleavage regardless of substrate sequence; the 3xK-APP monomeric mutant increases long Aβ production without altering initial ε-cleavage, demonstrating that primary sequence determines γ-secretase processivity independently of dimerization.","method":"Recombinant WT and 3xK-C100 substrates; isolation of monomeric/dimeric/trimeric forms; in vitro γ-secretase cleavage assay measuring ε-cleavage and Aβ production","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with recombinant substrates, isolation of distinct multimeric forms, and multiple cleavage readouts; single lab but rigorous biochemical approach","pmids":["25350374"],"is_preprint":false},{"year":2017,"finding":"ApoE secreted by glia binds ApoE receptors on neurons and activates DLK→MKK7→ERK1/2→cFos/AP-1 signaling, which enhances APP transcription and Aβ production with ApoE4 > ApoE3 > ApoE2 potency; this pathway also regulates APP transcription in mouse brain in vivo.","method":"ES-cell-derived human neurons co-cultured with glia; kinase inhibitors; transcription factor reporter assays; in vivo mouse brain validation; isoform-specific ApoE comparisons","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal signaling interventions, human neuronal model, in vivo validation, isoform rank-order confirmed","pmids":["28111074"],"is_preprint":false},{"year":2022,"finding":"SIRT2 deacetylates APP at lysines K132 and K134; inhibition or genetic deletion of SIRT2 enhances APP acetylation, promotes non-amyloidogenic processing at the cell surface (increased sAPPα), and ameliorates cognitive impairment in APP/PS1 mice.","method":"Acetylation site mapping (K132, K134); SIRT2 knockout and pharmacological inhibition; acetylation-mimic APP mutant expression; primary neuron Aβ42 challenge; APP/PS1 behavioral testing","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-specific PTM mapping with mutagenesis, bidirectional perturbation (KO + inhibitor), in vivo cognitive readout, single lab","pmids":["35830807"],"is_preprint":false},{"year":2014,"finding":"AICD interacts with FoxO in the cytoplasm, translocates with FoxO into the nucleus under oxidative stress, and acts as a transcriptional co-activator of FoxO to promote transcription of the pro-apoptotic gene Bim, mediating APP-induced cell death in Drosophila and mammalian cells.","method":"Drosophila genetic screen; co-immunoprecipitation (AICD-FoxO); nuclear fractionation under oxidative stress; luciferase reporter for FoxO-target Bim; loss-of-function phenotypes","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, subcellular fractionation, reporter assay, genetic screen across two organisms, single lab","pmids":["24832605"],"is_preprint":false},{"year":2017,"finding":"AICD upregulates JNK3 expression by interacting with the JNK3 gene locus (shown by chromatin immunoprecipitation and luciferase reporter assay); gamma-secretase inhibitors that block AICD production reduce JNK3 and phospho-JNK expression and protect retinal ganglion cells from axotomy-induced death.","method":"Mouse optic nerve axotomy model; microarray + ChIP + luciferase reporter for AICD at JNK3 locus; APP knockout; gamma-secretase inhibitor treatment; RGC survival counts","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with reporter validation, KO and pharmacological confirmation, in vivo functional readout, single lab","pmids":["29238071"],"is_preprint":false},{"year":2001,"finding":"Caspase cleavage of APP at its cytosolic tail removes the YENP endocytosis signal, reduces APP internalization, and decreases rather than increases Aβ secretion; masking the caspase site did not affect Aβ levels, and caspase activation by serum withdrawal did not increase Aβ secretion—indicating caspase cleavage of APP is unlikely to directly promote amyloidogenesis.","method":"Caspase-site masked APP mutants; serum-withdrawal caspase activation; internalization assays; Aβ ELISA","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis with functional internalization and processing readouts, single lab; finding is a negative mechanistic result","pmids":["11397796"],"is_preprint":false},{"year":2020,"finding":"Statins reduce APP processing by BACE1 by decreasing flAPP–BACE1 interaction and enhancing APP dimerization in a cholesterol-binding-dependent manner; statin-induced changes in APP dimerization and APP-BACE1 proximity require cholesterol binding to APP.","method":"iPSC-derived human neurons; bimolecular fluorescence complementation (BiFC) for APP dimerization; sAPPβ ELISA; cholesterol-binding mutants of APP","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BiFC dimerization assay with domain mutants and pharmacological intervention, human neuronal model, single lab","pmids":["33296223"],"is_preprint":false},{"year":2012,"finding":"FE65 interacts with VLDLR via its PTB1 domain and forms a trimeric complex with APP and VLDLR; this VLDLR–APP interaction alters trafficking and processing of both proteins, and FE65 presence increases the APP–VLDLR interaction in vitro and in vivo.","method":"GST pull-down; co-immunoprecipitation in COS7 cells and brain lysates; co-transfection processing assays","journal":"Molecular neurodegeneration","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — co-IP and pulldown from multiple sources confirm interaction and processing effect, but mechanistic detail limited, single lab","pmids":["22429478"],"is_preprint":false},{"year":2009,"finding":"p53 represses APP promoter activity via a mechanism involving DNA sequences downstream of the transcription start site (+55/+101); p53 reduces binding of transcription factor Sp1 to this region (shown by gel shift and ChIP), thereby lowering APP expression.","method":"Transient transfection with APP promoter deletion constructs; gel mobility shift assays; chromatin immunoprecipitation; dominant-negative p53; DNA-damaging drug camptothecin","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion mapping, EMSA, and ChIP confirm Sp1 displacement by p53, single lab","pmids":["19049493"],"is_preprint":false},{"year":2021,"finding":"APP expressed on GBM tumor cell surfaces inhibits phagocytosis of tumor-associated macrophages (TAMs) by binding to the CD74/CXCR4 receptor complex; APP binding to CD74 promotes SHP-1 phosphorylation, and disruption of the APP-CD74 axis upregulates TAM phagocytosis in vitro and in vivo.","method":"Cell-cell communication analysis; co-immunoprecipitation (APP–CD74/CXCR4); phospho-SHP-1 measurement; phagocytosis assay in vitro and in vivo","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single co-IP with functional phagocytosis assay, single lab, limited mechanistic depth in abstract","pmids":["39111632"],"is_preprint":false},{"year":2021,"finding":"Rab35 negatively regulates Aβ production by sorting APP and BACE1 out of the endosomal network via distinct effectors: OCRL mediates BACE1 sorting and ACAP2 mediates APP sorting; Rab35 overexpression prevents amyloidogenic trafficking of APP and BACE1 induced by glucocorticoids.","method":"Rab35 overexpression/knockdown in neurons; effector (OCRL, ACAP2) perturbation; Aβ ELISA; APP and BACE1 trafficking assays; glucocorticoid treatment model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional perturbation with effector mapping and pharmacological stress model, single lab","pmids":["34876559"],"is_preprint":false},{"year":2020,"finding":"Huntingtin (HTT), upon phosphorylation by Akt, regulates anterograde axonal transport of APP; expression of unphosphorylatable HTT decreases axonal transport of APP, reduces presynaptic APP levels, and increases synaptic density. In APPPS1 mice, ablating HTT phosphorylation in vivo reduced presynaptic APP and restored synapse number and memory.","method":"Microfluidic corticocortical neuronal network-on-a-chip; live imaging of APP transport; unphosphorylatable HTT knock-in mice crossed to APPPS1; synapse density counts; behavioral testing","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic manipulation (knock-in) with axonal transport imaging, in vivo synapse and behavioral readout, single lab","pmids":["32452382"],"is_preprint":false},{"year":2004,"finding":"In Drosophila, overexpression of APP, APLP1, APLP2, and Drosophila APPL induces Notch gain-of-function phenotypes in peripheral nervous system development; genetic analysis identified Numb as a target and implicated Disabled and Neurotactin, placing APP family members in the Notch signaling pathway during neuronal fate determination.","method":"Drosophila transgenics; genetic epistasis; appl mutant analysis; cell fate transformation scoring","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis across multiple APP family members with ortholog confirmation, single lab","pmids":["15385958"],"is_preprint":false},{"year":2000,"finding":"PKCα mediates PMA-regulated sAPP secretion in human NT2N neurons; long-term PMA treatment causing PKCα downregulation abolished both regulated and constitutive sAPP secretion in NT2N cells, demonstrating that PKCα is the primary isoform coupling PKC activation to alpha-secretase-dependent APP cleavage in neurons.","method":"PKC isoform-selective downregulation by prolonged PMA; pharmacological inhibitors (Calphostin C, GF109203X); membrane translocation assays; sAPP ELISA","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific functional loss with processing readout, pharmacological corroboration, single lab","pmids":["10858291"],"is_preprint":false},{"year":2008,"finding":"APP and BACE1 come into close proximity intracellularly but not at the cell surface in living cells, as shown by TIRET microscopy; altering cholesterol levels modulates this proximity and APP processing by BACE1, likely via changes in membrane fluidity.","method":"Time-resolved FRET combined with total internal reflection microscopy (TIRET) in living cells; sAPP secretion upon cholesterol manipulation","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — novel proximity imaging approach but single lab, limited functional validation of mechanism","pmids":["18374657"],"is_preprint":false}],"current_model":"APP is a type I transmembrane glycoprotein processed by three competing secretase pathways: β- and γ-secretases sequentially generate Aβ peptides (amyloidogenic pathway), while α-secretase (ADAM9/10/17) cleaves within the Aβ domain to release neuroprotective sAPPα (non-amyloidogenic pathway); APP trafficking through the secretory/endosomal pathway—regulated by phosphorylation at residues including Y682, Y687, and S655, by palmitoylation-driven dimerization, by adaptors FE65/Mint/PAT1a, and by retromer/Rab35-dependent sorting—determines which secretase gains access to APP; AICD released by γ-secretase acts as a transcriptional co-activator (with Fe65, FoxO, and at the WAVE1 and JNK3 loci) to regulate neurogenesis, apoptosis, and feedback inhibition of Aβ production; sAPPα supports dendritic spine maintenance and LTP; and APP interacts at the cell surface with TAG1, Synaptotagmins, BRI2, TrkA, GABA-B receptors, and CD74/CXCR4 to transduce extracellular signals into intracellular responses governing neuronal survival, migration, and synaptic function."},"narrative":{"mechanistic_narrative":"APP is a type I transmembrane glycoprotein whose proteolytic processing and intracellular trafficking govern neuronal survival, synaptic function, migration, and amyloid-β (Aβ) production [PMID:22884903, PMID:17873282]. APP is cleaved along competing pathways: α-secretase activity, contributed by ADAM9, ADAM10, and ADAM17 and coupled to neuronal PKCα activation, releases the trophic ectodomain sAPPα, which supports dendritic spine density and long-term potentiation [PMID:12535668, PMID:22884903, PMID:10858291], whereas β-secretase (BACE1) and γ-secretase generate Aβ and the APP-βCTF (C99) fragment, the latter raising lysosomal pH and inactivating cathepsin D to drive lysosomal dysfunction [PMID:31043483]. Which pathway predominates is set by APP trafficking and conformation: phosphorylation at Y687 and S655 directs APP between endocytic and secretory routes [PMID:17873282, PMID:19381782], cis-dimerization—initiated by ER disulfide bonds in the E1 domain and promoted by palmitoylation via DHHC7/DHHC21—favors BACE1 cleavage [PMID:22105709, PMID:27875558], and APP–BACE1 proximity is modulated by cholesterol binding [PMID:33296223, PMID:18374657]. Sorting adaptors and trafficking machinery including PAT1a, retromer (Vps35), and Rab35 (acting through effectors ACAP2 and OCRL) partition APP and BACE1 to limit amyloidogenic processing, while HTT-dependent axonal transport delivers APP to presynaptic terminals [PMID:17050537, PMID:21515373, PMID:34876559, PMID:32452382]. The γ-secretase product AICD acts as a transcriptional co-activator: with FE65 it transduces the extracellular ligand TAG1 to suppress neurogenesis, with FoxO it induces the pro-apoptotic gene Bim under oxidative stress, and it directly regulates the WAVE1/Wasf1 and JNK3 loci to control vesicular APP trafficking and neuronal death [PMID:18278038, PMID:26280122, PMID:24832605, PMID:29238071]. At the cell surface APP engages partners including TAG1, Synaptotagmins, BRI2, TrkA, and the CD74/CXCR4 complex to couple extracellular signals to processing, survival, and—in glioblastoma—inhibition of macrophage phagocytosis [PMID:18278038, PMID:16027166, PMID:21849536, PMID:26202512, PMID:39111632]. APP expression is further tuned post-transcriptionally by the mRNA-binding proteins hnRNP C and HuD and transcriptionally by an ApoE-driven DLK→MKK7→ERK→AP-1 cascade and p53/Sp1 promoter regulation [PMID:9649628, PMID:24857657, PMID:28111074, PMID:19049493].","teleology":[{"year":1998,"claim":"Established that APP abundance is controlled post-transcriptionally, identifying hnRNP C as a stabilizing 3'-UTR binder long before APP's many regulatory inputs were mapped.","evidence":"In vitro reticulocyte lysate translation with cis-element mutagenesis and RNA gel shift","pmids":["9649628"],"confidence":"Medium","gaps":["Whether hnRNP C regulates APP in neurons in vivo not addressed","Does not link expression level to Aβ output"]},{"year":2000,"claim":"Defined PKCα as the kinase isoform coupling PKC activation to regulated sAPP (α-secretase) secretion in neurons, connecting signaling to the non-amyloidogenic pathway.","evidence":"Isoform-selective PKC downregulation and pharmacological inhibition in human NT2N neurons with sAPP ELISA","pmids":["10858291"],"confidence":"Medium","gaps":["Direct phosphorylation target of PKCα on APP/secretase not identified","Mechanism linking PKCα to ADAM activity unresolved"]},{"year":2001,"claim":"Showed APP, with FE65, localizes to motility structures and accelerates cell migration, establishing a non-amyloid cell-biological role at focal complexes.","evidence":"Immunofluorescence co-localization and MDCK wound-healing migration assay with co-expression","pmids":["11425871"],"confidence":"Medium","gaps":["Molecular basis of migration enhancement (integrin signaling vs surface level) unclear","Relevance to neuronal migration in vivo not tested"]},{"year":2001,"claim":"Tested whether caspase cleavage of the APP tail drives amyloidogenesis, finding it instead removes the endocytosis signal and reduces Aβ—a negative result constraining apoptosis-amyloid models.","evidence":"Caspase-site-masked APP mutants and serum-withdrawal caspase activation with internalization and Aβ readouts","pmids":["11397796"],"confidence":"Medium","gaps":["Physiological role of caspase-cleaved APP fragment undefined","Single-cell-line context"]},{"year":2003,"claim":"Identified ADAM9/10/17 as the collective endogenous α-secretase, defining the enzymatic basis of the non-amyloidogenic cleavage.","evidence":"Overexpression in COS-7 and dsRNA knockdown of each ADAM in A172 cells measuring α-secretase activity","pmids":["12535668"],"confidence":"Medium","gaps":["Relative contribution of each ADAM in neurons not resolved","Regulation of ADAM access to APP not addressed"]},{"year":2003,"claim":"Linked neuronal activity to Aβ production and demonstrated Aβ depresses excitatory transmission via NMDA receptors, proposing an activity-dependent negative-feedback role.","evidence":"Hippocampal slice electrophysiology with APP overexpression and NMDA receptor blockade","pmids":["12670422"],"confidence":"Medium","gaps":["Molecular coupling of activity to secretase access undefined","Physiological vs pathological Aβ concentrations not delineated"]},{"year":2003,"claim":"Connected APP to neuronal apoptosis through APP-BP1 binding the C31 tail and a NEDD8-conjugation requirement, implicating ubiquitin-like signaling in APP-induced death.","evidence":"Co-IP, lipid raft fractionation, dominant-negative hUbc12, and neuronal apoptosis assay","pmids":["14557245"],"confidence":"Medium","gaps":["NEDD8 substrate driving apoptosis not identified","Relationship to AICD-dependent death pathways unclear"]},{"year":2004,"claim":"Placed APP family members in Notch signaling during neuronal fate determination via Numb, expanding APP function into developmental cell-fate control.","evidence":"Drosophila transgenics and genetic epistasis across APP/APLP1/APLP2/APPL","pmids":["15385958"],"confidence":"Medium","gaps":["Direct biochemical link between APP and Notch components missing","Conservation in mammalian neurogenesis untested here"]},{"year":2005,"claim":"Identified BRI2 as a cis-membrane transmembrane partner that shifts APP toward β-cleavage, an early example of a membrane partner steering processing.","evidence":"Reciprocal co-IP with transmembrane-domain deletion mapping and processing-product measurement","pmids":["16027166"],"confidence":"Medium","gaps":["In vivo neuronal relevance of BRI2-APP processing effect not shown","Mechanism by which complex favors BACE1 access unclear"]},{"year":2006,"claim":"Defined PAT1a as a TGN/endosomal adaptor binding APP's basolateral sorting signal and controlling surface levels and Aβ output, mechanistically linking sorting to processing.","evidence":"In vivo co-IP, primary neuron co-localization, bidirectional RNAi/overexpression with surface and Aβ readouts","pmids":["17050537"],"confidence":"Medium","gaps":["Structural basis of sorting-signal recognition undefined","Interplay with other adaptors not resolved"]},{"year":2007,"claim":"Demonstrated that Tyr687 phosphorylation status dictates APP endocytosis and choice of processing pathway, establishing a PTM switch for amyloidogenesis.","evidence":"Y687E/Y687F phosphomutant APP-GFP with live imaging, transferrin co-localization, and Aβ ELISA","pmids":["17873282"],"confidence":"Medium","gaps":["Kinase/phosphatase controlling Y687 not identified","In vivo significance not tested"]},{"year":2008,"claim":"Identified TAG1 as an extracellular ligand triggering γ-secretase/AICD release and Fe65-dependent suppression of neurogenesis, defining a receptor-like signaling axis for APP.","evidence":"Co-IP, genetic epistasis across TAG1/APP/Fe65 knockouts, and AICD-domain-mutant rescue in neural precursors","pmids":["18278038"],"confidence":"High","gaps":["Structural basis of TAG1-APP binding undefined","Generalization beyond neurogenesis not addressed"]},{"year":2008,"claim":"Localized APP-BACE1 encounter to intracellular compartments rather than the cell surface and showed cholesterol modulates this proximity.","evidence":"Time-resolved FRET with TIRF microscopy in living cells plus cholesterol manipulation and sAPP readout","pmids":["18374657"],"confidence":"Low","gaps":["Single-lab proximity imaging with limited functional validation","Specific compartment not identified"]},{"year":2009,"claim":"Established PKC-mediated S655 phosphorylation as a positive regulator of APP secretory exit from the Golgi favoring α-cleavage, complementing the Y687 switch.","evidence":"S655 phosphomimetic APP695-GFP mutants with Golgi dynamics imaging and sAPP quantification","pmids":["19381782"],"confidence":"Medium","gaps":["Direct kinase identity and link to PKCα not established","In vivo effect on Aβ not measured"]},{"year":2009,"claim":"Showed p53 represses the APP promoter by displacing Sp1, linking the DNA-damage response to APP transcription.","evidence":"Promoter deletion constructs, EMSA, ChIP, dominant-negative p53, and camptothecin treatment","pmids":["19049493"],"confidence":"Medium","gaps":["Neuronal/in vivo relevance not tested","Physiological trigger for p53 control of APP unclear"]},{"year":2011,"claim":"Defined sAPPα as the mediator of APP's trophic role at synapses, with APP knockout reducing spine density, arborization, and LTP and sAPPα rescuing spines.","evidence":"APP knockout mouse, hippocampal culture, in vivo spine counting, LTP electrophysiology, and sAPPα rescue","pmids":["22884903"],"confidence":"Medium","gaps":["sAPPα receptor mediating spine maintenance not identified","Partial rescue implies additional APP-dependent factors"]},{"year":2011,"claim":"Linked APP to NGF/TrkA neurotrophic signaling, showing TrkA phosphorylates APP at Y682 and APP reciprocally regulates TrkA distribution and NGF sensitivity.","evidence":"Co-IP, phosphospecific antibodies, and Y682 knock-in mice with neurotrophic survival assays","pmids":["21849536"],"confidence":"Medium","gaps":["Whether Y682 and Y687 events are coupled not resolved","Downstream survival effectors not mapped"]},{"year":2011,"claim":"Showed APP dimerization is initiated in the ER via E1-domain disulfide bonds and modulated by the KPI domain, establishing the structural origin of dimer-dependent processing.","evidence":"Organelle-retention constructs, non-reducing SDS-PAGE, E1 deletion mutants, and split-GFP in CHO-K1","pmids":["22105709"],"confidence":"Medium","gaps":["Functional consequence of ER dimerization for Aβ not directly tested here","Isoform-specific dimerization in neurons not shown"]},{"year":2011,"claim":"Implicated retromer in limiting amyloidogenic processing, with Vps35 loss raising Aβ42:Aβ40 and APP CTFs in exosomes.","evidence":"siRNA knockdown of Vps35 in HEK-293/APP695 with Aβ ELISA and exosome Western blot","pmids":["21515373"],"confidence":"Low","gaps":["Single-gene knockdown, single method per endpoint","Neuronal/in vivo confirmation lacking"]},{"year":2012,"claim":"Identified a FE65-bridged APP–VLDLR trimeric complex altering trafficking and processing of both proteins.","evidence":"GST pull-down and co-IP in COS7 and brain lysates with processing assays","pmids":["22429478"],"confidence":"Low","gaps":["Limited mechanistic detail and single-lab data","Functional consequence for Aβ in vivo unresolved"]},{"year":2014,"claim":"Established AICD as a FoxO co-activator that induces pro-apoptotic Bim under oxidative stress, defining a transcriptional route for APP-induced cell death.","evidence":"Drosophila genetic screen, AICD-FoxO co-IP, nuclear fractionation, and Bim luciferase reporter","pmids":["24832605"],"confidence":"Medium","gaps":["Relative contribution vs Fe65-dependent AICD targets unclear","Stress threshold for nuclear translocation undefined"]},{"year":2014,"claim":"Showed HuD post-transcriptionally stabilizes both APP and BACE1 mRNAs, coordinately raising Aβ in vivo.","evidence":"RNA immunoprecipitation, mRNA half-life measurement, and HuD-overexpressing transgenic mice","pmids":["24857657"],"confidence":"Medium","gaps":["Upstream control of HuD activity not addressed","Direct vs indirect BACE1 effect on Aβ not separated"]},{"year":2014,"claim":"Demonstrated that C99 multimerization impedes γ-secretase cleavage and that primary sequence sets processivity independent of dimerization, refining how Aβ length is determined.","evidence":"Recombinant C100 substrates with isolated multimeric forms in in vitro γ-secretase assays","pmids":["25350374"],"confidence":"High","gaps":["Cellular regulation of C99 multimer state unknown","Link to dimerization machinery (palmitoylation) not bridged here"]},{"year":2014,"claim":"Identified DISC1 as a direct APP partner controlling surface expression and internalization, shifting processing toward α-cleavage.","evidence":"RNAi in cortical neurons, co-IP, surface biotinylation, and APP-binding-domain-deletion rescue","pmids":["25224257"],"confidence":"Medium","gaps":["Trafficking step targeted by DISC1 not pinpointed","In vivo relevance to Aβ not tested"]},{"year":2015,"claim":"Defined a reciprocal AICD–WAVE1 circuit: AICD represses Wasf1 transcription while WAVE1 promotes APP vesicle budding and surface levels, with WAVE1 reduction rescuing AD-model memory.","evidence":"ChIP, co-IP, vesicle budding assay, Aβ ELISA, and in vivo Wasf1 reduction with behavior","pmids":["26280122"],"confidence":"High","gaps":["Whether the feedback loop is engaged under physiological conditions unclear","Spatial coordination of budding step undefined"]},{"year":2015,"claim":"Identified Synaptotagmins (Syt-1/2/9) as in vivo APP partners binding the E1-KPI linker and modulating BACE1-mediated Aβ generation.","evidence":"Brain affinity-purification MS, in vivo co-IP, GST domain mapping, and bidirectional Syt perturbation with Aβ ELISA","pmids":["26202512"],"confidence":"Medium","gaps":["Mechanism by which Syt promotes BACE1 access unresolved","Link to synaptic vesicle cycle vs processing not separated"]},{"year":2016,"claim":"Connected APP palmitoylation to dimer formation and β-cleavage, with DHHC7/DHHC21 driving palmitoylated dimers in detergent-resistant membranes preferred by BACE1.","evidence":"FLIM/FRET, co-IP, DHHC7/21 overexpression, palmitoylation inhibitors, and in vitro BACE1 assay on palAPP","pmids":["27875558"],"confidence":"Medium","gaps":["In vivo significance of palmitoylation-driven amyloidogenesis untested","Depalmitoylation enzymes not identified"]},{"year":2017,"claim":"Defined an ApoE-driven DLK→MKK7→ERK→AP-1 cascade that transcriptionally upregulates APP and Aβ with ApoE4>E3>E2 potency, linking the major AD risk gene to APP expression.","evidence":"ES-cell-derived human neurons co-cultured with glia, kinase inhibitors, reporter assays, and in vivo mouse validation","pmids":["28111074"],"confidence":"High","gaps":["ApoE receptor initiating the cascade not pinpointed","Contribution relative to ApoE effects on Aβ clearance not addressed"]},{"year":2017,"claim":"Showed AICD transcriptionally upregulates JNK3 to promote axotomy-induced retinal ganglion cell death, extending AICD's neuronal death program to a defined locus.","evidence":"Optic nerve axotomy, ChIP and luciferase at JNK3 locus, APP knockout, and γ-secretase inhibitor with RGC survival counts","pmids":["29238071"],"confidence":"Medium","gaps":["Whether JNK3 induction requires Fe65 not addressed","Relevance to Aβ-driven degeneration unclear"]},{"year":2019,"claim":"Identified APP-βCTF (C99) rather than Aβ as the driver of lysosomal dysfunction in Down syndrome by alkalinizing lysosomes and inactivating cathepsin D.","evidence":"DS fibroblasts and Ts2 neurons, direct lysosomal pH measurement, APP siRNA, BACE1 inhibition, and in vivo Bace1 deletion","pmids":["31043483"],"confidence":"High","gaps":["Mechanism by which C99 raises lysosomal pH undefined","Generalization beyond DS/trisomy context not established"]},{"year":2020,"claim":"Showed statins reduce BACE1 processing by enhancing cholesterol-binding-dependent APP dimerization and reducing APP-BACE1 proximity, linking lipid pharmacology to processing geometry.","evidence":"iPSC-derived neurons, BiFC dimerization, sAPPβ ELISA, and APP cholesterol-binding mutants","pmids":["33296223"],"confidence":"Medium","gaps":["Reconciliation with palmitoylation-driven dimer favoring β-cleavage unresolved","In vivo amyloid effect of statins not shown here"]},{"year":2020,"claim":"Demonstrated HTT phosphorylation by Akt drives anterograde axonal transport of APP, controlling presynaptic APP and synapse number in AD models.","evidence":"Microfluidic neuron-on-a-chip live imaging and unphosphorylatable HTT knock-in crossed to APPPS1 with synapse and behavior readouts","pmids":["32452382"],"confidence":"Medium","gaps":["Motor adaptors linking phospho-HTT to APP cargo not identified","Effect on Aβ load vs synapse number not separated"]},{"year":2021,"claim":"Defined Rab35 as a negative regulator of Aβ that sorts APP and BACE1 out of endosomes via distinct effectors ACAP2 and OCRL, countering stress-induced amyloidogenic trafficking.","evidence":"Rab35 perturbation, effector (OCRL/ACAP2) manipulation, glucocorticoid model, and trafficking/Aβ readouts in neurons","pmids":["34876559"],"confidence":"Medium","gaps":["Coordination with retromer-dependent sorting unclear","Upstream control of Rab35 activity undefined"]},{"year":2021,"claim":"Revealed a non-neuronal immune role: surface APP on glioblastoma binds CD74/CXCR4 and phosphorylates SHP-1 to suppress tumor-associated macrophage phagocytosis.","evidence":"Cell-cell communication analysis, APP-CD74/CXCR4 co-IP, phospho-SHP-1, and phagocytosis assays in vitro and in vivo","pmids":["39111632"],"confidence":"Low","gaps":["Single co-IP with limited mechanistic depth","Whether full-length APP or a fragment is the ligand unclear"]},{"year":null,"claim":"How the many converging trafficking adaptors, PTMs, dimerization states, and partner interactions are integrated in a single neuron to set the balance between trophic sAPPα signaling and amyloidogenic Aβ/C99 output remains unresolved.","evidence":"No single study reconciles the competing dimerization (palmitoylation vs cholesterol/statin), sorting (retromer/Rab35/PAT1a), and PTM (Y682/Y687/S655/acetylation) mechanisms into one quantitative model","pmids":[],"confidence":"Low","gaps":["No unified model of processing-pathway choice","Receptor(s) for sAPPα trophic signaling unidentified","Physiological vs pathological thresholds for AICD transcriptional programs undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,15,23,24]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,9,29]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,16,18,29,34]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[12,13,15]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[17]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[13,14,30]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,23,24]}],"pathway":[{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,21,30]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[15,23,24,28]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,5,18,20]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[13,14,30,31]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,9,21]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[7,23,24]}],"complexes":[],"partners":["FE65","TAG1","BRI2","TRKA","DISC1","VLDLR","BACE1","CD74"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P05067","full_name":"Amyloid-beta precursor protein","aliases":["ABPP","APPI","Alzheimer disease amyloid A4 protein homolog","Alzheimer disease amyloid protein","Amyloid precursor protein","Amyloid-beta (A4) precursor protein","Amyloid-beta A4 protein","Cerebral vascular amyloid peptide","CVAP","PreA4","Protease nexin-II","PN-II"],"length_aa":770,"mass_kda":86.9,"function":"Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed:17062754, PubMed:23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1 Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts More effective reductant than amyloid-beta protein 40. May activate mononuclear phagocytes in the brain and elicit inflammatory responses Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P05067/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APP","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/APP","total_profiled":1310},"omim":[{"mim_id":"620078","title":"FAMILY WITH SEQUENCE SIMILARITY 168, MEMBER B; FAM168B","url":"https://www.omim.org/entry/620078"},{"mim_id":"620048","title":"RETENTION IN ENDOPLASMIC RETICULUM SORTING RECEPTOR 1; RER1","url":"https://www.omim.org/entry/620048"},{"mim_id":"619684","title":"MITOCHONDRIA-LOCALIZED GLUTAMIC ACID-RICH PROTEIN; MGARP","url":"https://www.omim.org/entry/619684"},{"mim_id":"619429","title":"TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 2; TMCC2","url":"https://www.omim.org/entry/619429"},{"mim_id":"619405","title":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 30; SCAR30","url":"https://www.omim.org/entry/619405"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/APP"},"hgnc":{"alias_symbol":["alpha-sAPP"],"prev_symbol":["AD1"]},"alphafold":{"accession":"P05067","domains":[{"cath_id":"3.90.570.10","chopping":"27-121","consensus_level":"medium","plddt":86.8204,"start":27,"end":121},{"cath_id":"3.30.1490.140","chopping":"122-188","consensus_level":"medium","plddt":90.4221,"start":122,"end":188},{"cath_id":"4.10.410.10","chopping":"282-348","consensus_level":"high","plddt":87.181,"start":282,"end":348},{"cath_id":"1.20.120.770","chopping":"382-477","consensus_level":"medium","plddt":89.3047,"start":382,"end":477},{"cath_id":"1.20.120.770","chopping":"482-580","consensus_level":"medium","plddt":86.6018,"start":482,"end":580}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P05067","model_url":"https://alphafold.ebi.ac.uk/files/AF-P05067-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P05067-F1-predicted_aligned_error_v6.png","plddt_mean":67.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APP","jax_strain_url":"https://www.jax.org/strain/search?query=APP"},"sequence":{"accession":"P05067","fasta_url":"https://rest.uniprot.org/uniprotkb/P05067.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P05067/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P05067"}},"corpus_meta":[{"pmid":"12670422","id":"PMC_12670422","title":"APP processing and synaptic function.","date":"2003","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12670422","citation_count":1315,"is_preprint":false},{"pmid":"22553493","id":"PMC_22553493","title":"Trafficking and proteolytic processing of APP.","date":"2012","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22553493","citation_count":832,"is_preprint":false},{"pmid":"21214928","id":"PMC_21214928","title":"APP processing in Alzheimer's disease.","date":"2011","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/21214928","citation_count":726,"is_preprint":false},{"pmid":"20232515","id":"PMC_20232515","title":"An overview of APP processing enzymes and products.","date":"2010","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20232515","citation_count":518,"is_preprint":false},{"pmid":"28111074","id":"PMC_28111074","title":"ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28111074","citation_count":439,"is_preprint":false},{"pmid":"12535668","id":"PMC_12535668","title":"Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12535668","citation_count":233,"is_preprint":false},{"pmid":"22355794","id":"PMC_22355794","title":"Physiological functions of APP family proteins.","date":"2012","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22355794","citation_count":223,"is_preprint":false},{"pmid":"11425871","id":"PMC_11425871","title":"The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11425871","citation_count":191,"is_preprint":false},{"pmid":"18278038","id":"PMC_18278038","title":"A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis.","date":"2008","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18278038","citation_count":181,"is_preprint":false},{"pmid":"24103387","id":"PMC_24103387","title":"The role of APP and BACE1 trafficking in APP processing and amyloid-β generation.","date":"2013","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24103387","citation_count":177,"is_preprint":false},{"pmid":"18684319","id":"PMC_18684319","title":"MicroRNAs can regulate human APP levels.","date":"2008","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/18684319","citation_count":166,"is_preprint":false},{"pmid":"12824062","id":"PMC_12824062","title":"Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease.","date":"2003","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12824062","citation_count":153,"is_preprint":false},{"pmid":"18564425","id":"PMC_18564425","title":"Interactions between APP secretases and inflammatory mediators.","date":"2008","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/18564425","citation_count":144,"is_preprint":false},{"pmid":"22884903","id":"PMC_22884903","title":"Amyloid precursor protein (APP) regulates synaptic structure and function.","date":"2012","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/22884903","citation_count":141,"is_preprint":false},{"pmid":"19021541","id":"PMC_19021541","title":"Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.","date":"2008","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/19021541","citation_count":126,"is_preprint":false},{"pmid":"21785276","id":"PMC_21785276","title":"The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.","date":"2011","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/21785276","citation_count":123,"is_preprint":false},{"pmid":"31043483","id":"PMC_31043483","title":"Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31043483","citation_count":123,"is_preprint":false},{"pmid":"17371289","id":"PMC_17371289","title":"The APP family of proteins: similarities and differences.","date":"2007","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/17371289","citation_count":112,"is_preprint":false},{"pmid":"9649628","id":"PMC_9649628","title":"hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA.","date":"1998","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9649628","citation_count":105,"is_preprint":false},{"pmid":"16027166","id":"PMC_16027166","title":"BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16027166","citation_count":101,"is_preprint":false},{"pmid":"24857657","id":"PMC_24857657","title":"HuD regulates coding and noncoding RNA to induce APP→Aβ processing.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24857657","citation_count":98,"is_preprint":false},{"pmid":"28344547","id":"PMC_28344547","title":"APP Function and Lipids: A Bidirectional Link.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28344547","citation_count":89,"is_preprint":false},{"pmid":"26837733","id":"PMC_26837733","title":"APP Receptor? To Be or Not To Be.","date":"2016","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26837733","citation_count":88,"is_preprint":false},{"pmid":"26296890","id":"PMC_26296890","title":"Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26296890","citation_count":84,"is_preprint":false},{"pmid":"8567065","id":"PMC_8567065","title":"Amyloid precursor protein (APP) expression in multiple sclerosis lesions.","date":"1995","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/8567065","citation_count":82,"is_preprint":false},{"pmid":"21515373","id":"PMC_21515373","title":"Retromer disruption promotes amyloidogenic APP processing.","date":"2011","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/21515373","citation_count":82,"is_preprint":false},{"pmid":"21769132","id":"PMC_21769132","title":"APP physiological and pathophysiological functions: insights from animal models.","date":"2011","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/21769132","citation_count":77,"is_preprint":false},{"pmid":"14557245","id":"PMC_14557245","title":"APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14557245","citation_count":77,"is_preprint":false},{"pmid":"21960299","id":"PMC_21960299","title":"Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.","date":"2011","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21960299","citation_count":76,"is_preprint":false},{"pmid":"21199446","id":"PMC_21199446","title":"The upside of APP at synapses.","date":"2010","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21199446","citation_count":75,"is_preprint":false},{"pmid":"29383688","id":"PMC_29383688","title":"Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29383688","citation_count":74,"is_preprint":false},{"pmid":"28210211","id":"PMC_28210211","title":"APP as a Protective Factor in Acute Neuronal Insults.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28210211","citation_count":73,"is_preprint":false},{"pmid":"12383342","id":"PMC_12383342","title":"The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog?","date":"2002","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/12383342","citation_count":67,"is_preprint":false},{"pmid":"34066808","id":"PMC_34066808","title":"Molecular Characteristics of Amyloid Precursor Protein (APP) and Its Effects in Cancer.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34066808","citation_count":64,"is_preprint":false},{"pmid":"14570401","id":"PMC_14570401","title":"Protein phosphorylation and APP metabolism.","date":"2003","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/14570401","citation_count":63,"is_preprint":false},{"pmid":"21152995","id":"PMC_21152995","title":"APP transgenic mice: their use and limitations.","date":"2010","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21152995","citation_count":63,"is_preprint":false},{"pmid":"15385958","id":"PMC_15385958","title":"Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15385958","citation_count":60,"is_preprint":false},{"pmid":"22514144","id":"PMC_22514144","title":"Novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers.","date":"2012","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22514144","citation_count":60,"is_preprint":false},{"pmid":"11397796","id":"PMC_11397796","title":"The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11397796","citation_count":58,"is_preprint":false},{"pmid":"28799137","id":"PMC_28799137","title":"Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28799137","citation_count":58,"is_preprint":false},{"pmid":"18220928","id":"PMC_18220928","title":"Activity of gamma-secretase on substrates other than APP.","date":"2008","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18220928","citation_count":58,"is_preprint":false},{"pmid":"23102935","id":"PMC_23102935","title":"Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population.","date":"2012","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/23102935","citation_count":58,"is_preprint":false},{"pmid":"24832605","id":"PMC_24832605","title":"FoxO mediates APP-induced AICD-dependent cell death.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24832605","citation_count":57,"is_preprint":false},{"pmid":"11816790","id":"PMC_11816790","title":"Implication of APP secretases in notch signaling.","date":"2001","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/11816790","citation_count":57,"is_preprint":false},{"pmid":"24175176","id":"PMC_24175176","title":"Platelets and Alzheimer's disease: Potential of APP as a biomarker.","date":"2012","source":"World journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24175176","citation_count":55,"is_preprint":false},{"pmid":"11532129","id":"PMC_11532129","title":"Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis.","date":"2001","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11532129","citation_count":54,"is_preprint":false},{"pmid":"28298885","id":"PMC_28298885","title":"Functional Roles of the Interaction of APP and Lipoprotein Receptors.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28298885","citation_count":53,"is_preprint":false},{"pmid":"21849536","id":"PMC_21849536","title":"APP is phosphorylated by TrkA and regulates NGF/TrkA signaling.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21849536","citation_count":53,"is_preprint":false},{"pmid":"18374657","id":"PMC_18374657","title":"Impact of cholesterol level upon APP and BACE proximity and APP cleavage.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18374657","citation_count":51,"is_preprint":false},{"pmid":"20167227","id":"PMC_20167227","title":"The functional neurophysiology of the amyloid precursor protein (APP) processing pathway.","date":"2010","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20167227","citation_count":50,"is_preprint":false},{"pmid":"34745458","id":"PMC_34745458","title":"ggVolcanoR: A Shiny app for customizable visualization of differential expression datasets.","date":"2021","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/34745458","citation_count":50,"is_preprint":false},{"pmid":"27062894","id":"PMC_27062894","title":"AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease.","date":"2016","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/27062894","citation_count":49,"is_preprint":false},{"pmid":"30500566","id":"PMC_30500566","title":"The amyloid precursor protein (APP) processing as a biological link between Alzheimer's disease and cancer.","date":"2018","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30500566","citation_count":49,"is_preprint":false},{"pmid":"35830807","id":"PMC_35830807","title":"Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35830807","citation_count":47,"is_preprint":false},{"pmid":"25224257","id":"PMC_25224257","title":"DISC1 regulates trafficking and processing of APP and Aβ generation.","date":"2014","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25224257","citation_count":47,"is_preprint":false},{"pmid":"15679106","id":"PMC_15679106","title":"Biological roles of APP in the epidermis.","date":"2004","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15679106","citation_count":45,"is_preprint":false},{"pmid":"25604855","id":"PMC_25604855","title":"Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/25604855","citation_count":42,"is_preprint":false},{"pmid":"17873282","id":"PMC_17873282","title":"Tyr687 dependent APP endocytosis and Abeta production.","date":"2007","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/17873282","citation_count":42,"is_preprint":false},{"pmid":"16909010","id":"PMC_16909010","title":"APP processing and the APP-KPI domain involvement in the amyloid cascade.","date":"2005","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/16909010","citation_count":41,"is_preprint":false},{"pmid":"28539872","id":"PMC_28539872","title":"The Role of APP in Structural Spine Plasticity.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28539872","citation_count":41,"is_preprint":false},{"pmid":"26280122","id":"PMC_26280122","title":"APP intracellular domain-WAVE1 pathway reduces amyloid-β production.","date":"2015","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26280122","citation_count":41,"is_preprint":false},{"pmid":"19381782","id":"PMC_19381782","title":"S655 phosphorylation enhances APP secretory traffic.","date":"2009","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19381782","citation_count":41,"is_preprint":false},{"pmid":"32341983","id":"PMC_32341983","title":"β-Amyloid precursor protein (APP) and the human diseases.","date":"2019","source":"AIMS neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32341983","citation_count":40,"is_preprint":false},{"pmid":"23089603","id":"PMC_23089603","title":"Neurologic and motor dysfunctions in APP transgenic mice.","date":"2012","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/23089603","citation_count":40,"is_preprint":false},{"pmid":"21196064","id":"PMC_21196064","title":"Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/21196064","citation_count":39,"is_preprint":false},{"pmid":"29955650","id":"PMC_29955650","title":"Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse.","date":"2018","source":"Alzheimer's & dementia (New York, N. Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29955650","citation_count":39,"is_preprint":false},{"pmid":"18554321","id":"PMC_18554321","title":"Functional interactions of APP with the apoE receptor family.","date":"2008","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18554321","citation_count":38,"is_preprint":false},{"pmid":"22105709","id":"PMC_22105709","title":"APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms.","date":"2011","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22105709","citation_count":38,"is_preprint":false},{"pmid":"26202512","id":"PMC_26202512","title":"Synaptotagmins interact with APP and promote Aβ generation.","date":"2015","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/26202512","citation_count":36,"is_preprint":false},{"pmid":"27401064","id":"PMC_27401064","title":"Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.","date":"2017","source":"CNS & neurological disorders drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/27401064","citation_count":36,"is_preprint":false},{"pmid":"31969805","id":"PMC_31969805","title":"Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice.","date":"2020","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31969805","citation_count":35,"is_preprint":false},{"pmid":"33296223","id":"PMC_33296223","title":"Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization.","date":"2020","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/33296223","citation_count":33,"is_preprint":false},{"pmid":"17050537","id":"PMC_17050537","title":"PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17050537","citation_count":33,"is_preprint":false},{"pmid":"15192323","id":"PMC_15192323","title":"APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin.","date":"2004","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/15192323","citation_count":32,"is_preprint":false},{"pmid":"22429478","id":"PMC_22429478","title":"FE65 as a link between VLDLR and APP to regulate their trafficking and processing.","date":"2012","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/22429478","citation_count":32,"is_preprint":false},{"pmid":"19049493","id":"PMC_19049493","title":"The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP).","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19049493","citation_count":32,"is_preprint":false},{"pmid":"35223832","id":"PMC_35223832","title":"Exosomes Mediate APP Dysregulation via APP-miR-185-5p Axis.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35223832","citation_count":31,"is_preprint":false},{"pmid":"29238071","id":"PMC_29238071","title":"APP upregulation contributes to retinal ganglion cell degeneration via JNK3.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29238071","citation_count":30,"is_preprint":false},{"pmid":"22727994","id":"PMC_22727994","title":"Good gene, bad gene: new APP variant may be both.","date":"2012","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22727994","citation_count":29,"is_preprint":false},{"pmid":"37262102","id":"PMC_37262102","title":"Exercise training and BDNF injections alter amyloid precursor protein (APP) processing enzymes and improve cognition.","date":"2023","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/37262102","citation_count":29,"is_preprint":false},{"pmid":"10858291","id":"PMC_10858291","title":"Regulation of amyloid precursor protein (APP) secretion by protein kinase calpha in human ntera 2 neurons (NT2N).","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10858291","citation_count":29,"is_preprint":false},{"pmid":"39111632","id":"PMC_39111632","title":"Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM.","date":"2024","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/39111632","citation_count":28,"is_preprint":false},{"pmid":"27875558","id":"PMC_27875558","title":"Palmitoylated APP Forms Dimers, Cleaved by BACE1.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27875558","citation_count":28,"is_preprint":false},{"pmid":"25350374","id":"PMC_25350374","title":"Independent relationship between amyloid precursor protein (APP) dimerization and γ-secretase processivity.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25350374","citation_count":28,"is_preprint":false},{"pmid":"9791531","id":"PMC_9791531","title":"Monogenetic determinants of Alzheimer's disease: APP mutations.","date":"1998","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/9791531","citation_count":27,"is_preprint":false},{"pmid":"24573290","id":"PMC_24573290","title":"UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24573290","citation_count":27,"is_preprint":false},{"pmid":"28424586","id":"PMC_28424586","title":"APP Protein Family Signaling at the Synapse: Insights from Intracellular APP-Binding Proteins.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28424586","citation_count":26,"is_preprint":false},{"pmid":"25447788","id":"PMC_25447788","title":"Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway.","date":"2014","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25447788","citation_count":26,"is_preprint":false},{"pmid":"11106509","id":"PMC_11106509","title":"Protein kinase C regulation of intracellular and cell surface amyloid precursor protein (APP) cleavage in CHO695 cells.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11106509","citation_count":26,"is_preprint":false},{"pmid":"15657641","id":"PMC_15657641","title":"Amyloid precursor protein (APP) and its derivatives change after cellular energy depletion. An in vitro-study.","date":"2004","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/15657641","citation_count":25,"is_preprint":false},{"pmid":"33914267","id":"PMC_33914267","title":"The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33914267","citation_count":24,"is_preprint":false},{"pmid":"31174368","id":"PMC_31174368","title":"Amyloid Precursor Protein (APP) and GABAergic Neurotransmission.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31174368","citation_count":23,"is_preprint":false},{"pmid":"34876559","id":"PMC_34876559","title":"Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34876559","citation_count":23,"is_preprint":false},{"pmid":"32452382","id":"PMC_32452382","title":"Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32452382","citation_count":23,"is_preprint":false},{"pmid":"35807406","id":"PMC_35807406","title":"A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35807406","citation_count":23,"is_preprint":false},{"pmid":"18415033","id":"PMC_18415033","title":"Regulated proteolysis of APP and ApoE receptors.","date":"2008","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18415033","citation_count":22,"is_preprint":false},{"pmid":"21947084","id":"PMC_21947084","title":"The role of lipoprotein receptors on the physiological function of APP.","date":"2011","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21947084","citation_count":22,"is_preprint":false},{"pmid":"24404197","id":"PMC_24404197","title":"Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24404197","citation_count":22,"is_preprint":false},{"pmid":"31744937","id":"PMC_31744937","title":"Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31744937","citation_count":22,"is_preprint":false},{"pmid":"35822056","id":"PMC_35822056","title":"Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA.","date":"2021","source":"Frontiers in aging","url":"https://pubmed.ncbi.nlm.nih.gov/35822056","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44595,"output_tokens":8599,"usd":0.131385,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18638,"output_tokens":9448,"usd":0.164695,"stage2_stop_reason":"end_turn"},"total_usd":0.29608,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Neuronal activity modulates formation and secretion of Aβ peptides from APP in hippocampal slice neurons; in turn, Aβ selectively depresses excitatory synaptic transmission in an NMDA receptor-dependent manner, suggesting activity-dependent Aβ production participates in a negative feedback on neuronal hyperactivity.\",\n      \"method\": \"Hippocampal slice electrophysiology with APP overexpression, pharmacological blockade of NMDA receptors\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional electrophysiological readout in slice neurons with pharmacological dissection, single lab\",\n      \"pmids\": [\"12670422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ADAM9, ADAM10, and ADAM17 each catalyze alpha-secretase cleavage of APP; dsRNA knockdown of each individually in human glioblastoma A172 cells reduced endogenous alpha-secretase activity, indicating these ADAMs collectively constitute the endogenous alpha-secretase.\",\n      \"method\": \"Overexpression in COS-7 cells measuring constitutive and regulated alpha-secretase activity; dsRNA knockdown in A172 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal approaches (OE and RNAi), single lab\",\n      \"pmids\": [\"12535668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"APP and FE65 colocalize with actin and Mena in lamellipodia and concentrate with β1-integrin in focal complexes; overexpression of APP accelerates cell migration, and co-expression of FE65 dramatically enhances this effect, likely by regulating APP surface levels.\",\n      \"method\": \"Co-localization by immunofluorescence; MDCK wound-healing migration assay; co-expression studies\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence (migration assay), single lab, two methods\",\n      \"pmids\": [\"11425871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TAG1 acts as an extracellular functional ligand of APP; TAG1-APP interaction triggers γ-secretase-dependent AICD release and Fe65-dependent signaling, negatively modulating neurogenesis. Genetic epistasis in TAG1−/−, APP−/−, and Fe65−/− mice confirmed the TAG1→APP→Fe65 pathway order.\",\n      \"method\": \"Co-immunoprecipitation, genetic epistasis using knockout mice, rescue with AICD or AICD Fe65-binding mutant in neural precursor cells\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction data, genetic epistasis across multiple KO lines, functional rescue with domain mutant\",\n      \"pmids\": [\"18278038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Lysosomal dysfunction in Down syndrome requires the extra APP gene copy and is specifically mediated by elevated APP-βCTF (C99); APP-βCTF raises lysosomal pH (~0.6 units), inactivating cathepsin D and other hydrolases. BACE1 inhibition or siRNA knockdown of APP reversed these deficits.\",\n      \"method\": \"Primary DS fibroblasts and Ts2 mouse neurons; direct lysosomal pH measurement; siRNA knockdown of APP; BACE1 inhibitor treatment; in vivo Bace1 allele deletion in Ts2 mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (pH measurement, siRNA, pharmacological inhibition, in vivo genetics), replicated across cell and mouse models\",\n      \"pmids\": [\"31043483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BRI2 physically interacts with APP via their transmembrane domains (APP residues 648–719; BRI2 residues 46–106); this interaction is cis (same membrane) and increases cellular APP levels and β-secretase CTFs while decreasing α-secretase CTFs and Aβ secretion.\",\n      \"method\": \"Co-immunoprecipitation in transfected and non-transfected cells; deletion mutagenesis to map interaction domains; measurement of APP processing products\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with deletion mapping and functional processing readout, single lab\",\n      \"pmids\": [\"16027166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"hnRNP C binds a 29-nt element in the 3'-UTR of APP mRNA and stabilizes it; supplementing a reticulocyte lysate translation system with exogenous hnRNP C stabilized wild-type APP mRNA and increased APP protein synthesis ~6-fold, while mRNAs lacking the 29-nt element were unaffected.\",\n      \"method\": \"In vitro rabbit reticulocyte lysate translation; RNA gel mobility shift assays; mutant APP mRNA lacking 29-nt element\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with cis-element mutagenesis, single lab\",\n      \"pmids\": [\"9649628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"APP-BP1 binds the C-terminal 31 amino acids (C31) of APP and colocalizes with APP in lipid rafts; coexpression of the APP-BP1 domain that binds APP abolishes APP-induced neuronal apoptosis and aberrant DNA synthesis, and a dominant-negative NEDD8-conjugating enzyme hUbc12 similarly blocks neuronal apoptosis caused by APP.\",\n      \"method\": \"Co-immunoprecipitation; lipid raft fractionation; dominant-negative hUbc12 overexpression; neuronal apoptosis assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding mapping, subcellular fractionation, and functional rescue by dominant-negative, single lab\",\n      \"pmids\": [\"14557245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"APP knockout reduces dendritic spine density (~35% in culture, ~15% in vivo in 12–15-month mice) and dendritic arborization in hippocampal neurons, and impairs long-term potentiation; addition of sAPPα-conditioned medium partially restores spine density, indicating sAPPα mediates APP's trophic role at synapses.\",\n      \"method\": \"APP knockout mouse; primary hippocampal neuron culture; in vivo spine counting in CA1; LTP electrophysiology; sAPPα rescue experiment\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with multiple phenotypic readouts and ligand rescue, single lab\",\n      \"pmids\": [\"22884903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"APP is phosphorylated at Y682 by TrkA upon NGF stimulation; APP physically interacts with TrkA in a Y682-dependent manner, and APP/Y682 in turn regulates activation of the NGF/TrkA signaling pathway in vivo, the subcellular distribution of TrkA, and neuronal sensitivity to NGF.\",\n      \"method\": \"Co-immunoprecipitation; phosphospecific antibodies; in vivo analysis in Y682 knock-in mice; neurotrophic survival assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, in vivo genetic model with Y682 mutation, single lab\",\n      \"pmids\": [\"21849536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HuD RNA-binding protein binds the 3'-UTRs of APP and BACE1 mRNAs and increases their half-lives; HuD-overexpressing mice show elevated APP, BACE1, and Aβ levels in brain, establishing HuD as a post-transcriptional regulator of APP expression.\",\n      \"method\": \"RNA immunoprecipitation (RIP); mRNA half-life measurement; HuD-overexpressing transgenic mice; quantification of APP, BACE1, Aβ levels\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP with mRNA stability assay and in vivo validation in transgenic mice, single lab\",\n      \"pmids\": [\"24857657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Phosphomimicking Tyr687 (Y687E) prevents APP endocytosis and dramatically reduces Aβ production, whereas dephosphomimicking (Y687F) preserves endocytosis and favors β-secretase cleavage, demonstrating that Tyr687 phosphorylation status determines APP subcellular targeting and processing pathway.\",\n      \"method\": \"APP-GFP fusion phosphomutants (Y687E and Y687F); live cell imaging; transferrin co-localization; Aβ ELISA\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis with functional processing readout and localization data, single lab\",\n      \"pmids\": [\"17873282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PKC-mediated phosphorylation of APP at S655 positively modulates APP secretory traffic; phosphomimicking S655 mutants exhibit enhanced Golgi vesicular exit and increased secretory (alpha-secretase) cleavage to sAPP compared to dephosphomimicking mutants.\",\n      \"method\": \"APP695-GFP S655 phosphomutants; Golgi dynamics imaging; sAPP secretion quantification\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis with trafficking and processing readout, single lab\",\n      \"pmids\": [\"19381782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAT1a binds APP, APLP1, and APLP2 intracellular domains in vivo and co-localizes with them in trans-Golgi network vesicles/endosomes in primary neurons; PAT1a directly interacts with the basolateral sorting signal of APP/APLPs and its overexpression or RNAi knockdown modulates APP cell-surface levels and processing, altering Aβ secretion.\",\n      \"method\": \"Co-immunoprecipitation in vivo; co-localization in primary neurons; RNAi knockdown and overexpression; cell-surface APP quantification; Aβ ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, bidirectional perturbation (OE+KD) with functional readout, single lab\",\n      \"pmids\": [\"17050537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Retromer deficiency (Vps35 knockdown) increases the ratio of secreted Aβ42:Aβ40 and elevates APP C-terminal fragments in exosomes, indicating that retromer-mediated retrograde transport limits amyloidogenic APP processing in late endosomes.\",\n      \"method\": \"siRNA knockdown of Vps35 in HEK-293/APP695 cells; Aβ ELISA; exosome isolation and Western blotting\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single-gene knockdown with processing readout, single lab, single method per endpoint\",\n      \"pmids\": [\"21515373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"AICD binds the Wasf1 (WAVE1) promoter and negatively regulates WAVE1 transcription; WAVE1 interacts and colocalizes with APP in the Golgi apparatus and promotes APP-containing vesicle budding and cell-surface APP levels; reducing WAVE1 decreased Aβ production and restored memory deficits in AD mice.\",\n      \"method\": \"Chromatin immunoprecipitation (AICD at Wasf1 promoter); co-immunoprecipitation (WAVE1–APP); vesicle budding assay; Aβ ELISA; in vivo Wasf1 genetic reduction in AD mouse model; behavioral testing\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, co-IP, functional vesicle assay, in vivo genetic rescue with behavioral readout, multiple orthogonal methods in single study\",\n      \"pmids\": [\"26280122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DISC1 interacts directly with APP and regulates its surface expression and internalization; DISC1 knockdown increases cell-surface APP, reduces APP internalization, and shifts processing toward alpha-cleavage (elevated sAPPα/APP-CTFα, decreased Aβ); rescue required wild-type DISC1 but not a DISC1 mutant lacking the APP-binding domain.\",\n      \"method\": \"RNAi knockdown in primary cortical neurons; co-immunoprecipitation; cell-surface biotinylation; Western blot; Aβ ELISA\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain-deletion mutant rescue and bidirectional functional readout, single lab\",\n      \"pmids\": [\"25224257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"APP dimer formation is initiated in the endoplasmic reticulum via intermolecular disulfide bonds between cysteines in the extracellular E1 domain; APP isoforms containing the KPI domain show strongly reduced cis-dimerization; dimers formed in the ER remain stably associated at the cell surface.\",\n      \"method\": \"Organelle-retention APP constructs (KKAA-ER, KKFF-Golgi) in CHO-K1 cells; non-reducing SDS-PAGE; E1 domain deletion mutants; split-GFP; cell aggregation assay\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with mutagenesis (domain deletion) and complementary split-GFP, single lab\",\n      \"pmids\": [\"22105709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Synaptotagmins (Syt-1, -2, -9) interact with APP in mouse brains in vivo via the 108-amino-acid linker region between E1 and KPI domains; stable overexpression of Syt-1 or Syt-9 increases APP-CTF, sAPP, and Aβ ~2–3-fold, while Syt-1 knockdown reduces Aβ40/42 and sAPPβ, indicating Syt-1 regulates Aβ generation by modulating BACE1-mediated APP cleavage.\",\n      \"method\": \"Affinity purification-coupled mass spectrometry from mouse brains; co-IP in cells and in vivo; GST pull-down domain mapping; stable OE and lentiviral KD; Aβ ELISA\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo co-IP, domain mapping, bidirectional perturbation with processing readout, single lab\",\n      \"pmids\": [\"26202512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Palmitoylated APP (palAPP) forms dimers preferentially (~90% vs ~20% of total APP); palAPP dimers are predominantly cis-oriented and favor BACE1-mediated β-cleavage over total APP in lipid-rich detergent-resistant membranes; enzymes DHHC7 and DHHC21 increase both palmitoylation and APP dimerization, and pharmacological inhibition of palmitoylation reduces APP dimerization.\",\n      \"method\": \"FLIM/FRET and co-immunoprecipitation for dimerization; DHHC7/DHHC21 overexpression; palmitoylation inhibitors; in vitro BACE1 activity assay with isolated palAPP vs total APP\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro BACE1 activity assay with purified substrates + FRET dimerization + mutagenesis-like pharmacological inhibition, single lab\",\n      \"pmids\": [\"27875558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Multimerization of APP CTFβ (C99) significantly impedes γ-secretase cleavage regardless of substrate sequence; the 3xK-APP monomeric mutant increases long Aβ production without altering initial ε-cleavage, demonstrating that primary sequence determines γ-secretase processivity independently of dimerization.\",\n      \"method\": \"Recombinant WT and 3xK-C100 substrates; isolation of monomeric/dimeric/trimeric forms; in vitro γ-secretase cleavage assay measuring ε-cleavage and Aβ production\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with recombinant substrates, isolation of distinct multimeric forms, and multiple cleavage readouts; single lab but rigorous biochemical approach\",\n      \"pmids\": [\"25350374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ApoE secreted by glia binds ApoE receptors on neurons and activates DLK→MKK7→ERK1/2→cFos/AP-1 signaling, which enhances APP transcription and Aβ production with ApoE4 > ApoE3 > ApoE2 potency; this pathway also regulates APP transcription in mouse brain in vivo.\",\n      \"method\": \"ES-cell-derived human neurons co-cultured with glia; kinase inhibitors; transcription factor reporter assays; in vivo mouse brain validation; isoform-specific ApoE comparisons\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal signaling interventions, human neuronal model, in vivo validation, isoform rank-order confirmed\",\n      \"pmids\": [\"28111074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SIRT2 deacetylates APP at lysines K132 and K134; inhibition or genetic deletion of SIRT2 enhances APP acetylation, promotes non-amyloidogenic processing at the cell surface (increased sAPPα), and ameliorates cognitive impairment in APP/PS1 mice.\",\n      \"method\": \"Acetylation site mapping (K132, K134); SIRT2 knockout and pharmacological inhibition; acetylation-mimic APP mutant expression; primary neuron Aβ42 challenge; APP/PS1 behavioral testing\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-specific PTM mapping with mutagenesis, bidirectional perturbation (KO + inhibitor), in vivo cognitive readout, single lab\",\n      \"pmids\": [\"35830807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"AICD interacts with FoxO in the cytoplasm, translocates with FoxO into the nucleus under oxidative stress, and acts as a transcriptional co-activator of FoxO to promote transcription of the pro-apoptotic gene Bim, mediating APP-induced cell death in Drosophila and mammalian cells.\",\n      \"method\": \"Drosophila genetic screen; co-immunoprecipitation (AICD-FoxO); nuclear fractionation under oxidative stress; luciferase reporter for FoxO-target Bim; loss-of-function phenotypes\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, subcellular fractionation, reporter assay, genetic screen across two organisms, single lab\",\n      \"pmids\": [\"24832605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"AICD upregulates JNK3 expression by interacting with the JNK3 gene locus (shown by chromatin immunoprecipitation and luciferase reporter assay); gamma-secretase inhibitors that block AICD production reduce JNK3 and phospho-JNK expression and protect retinal ganglion cells from axotomy-induced death.\",\n      \"method\": \"Mouse optic nerve axotomy model; microarray + ChIP + luciferase reporter for AICD at JNK3 locus; APP knockout; gamma-secretase inhibitor treatment; RGC survival counts\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with reporter validation, KO and pharmacological confirmation, in vivo functional readout, single lab\",\n      \"pmids\": [\"29238071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Caspase cleavage of APP at its cytosolic tail removes the YENP endocytosis signal, reduces APP internalization, and decreases rather than increases Aβ secretion; masking the caspase site did not affect Aβ levels, and caspase activation by serum withdrawal did not increase Aβ secretion—indicating caspase cleavage of APP is unlikely to directly promote amyloidogenesis.\",\n      \"method\": \"Caspase-site masked APP mutants; serum-withdrawal caspase activation; internalization assays; Aβ ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis with functional internalization and processing readouts, single lab; finding is a negative mechanistic result\",\n      \"pmids\": [\"11397796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Statins reduce APP processing by BACE1 by decreasing flAPP–BACE1 interaction and enhancing APP dimerization in a cholesterol-binding-dependent manner; statin-induced changes in APP dimerization and APP-BACE1 proximity require cholesterol binding to APP.\",\n      \"method\": \"iPSC-derived human neurons; bimolecular fluorescence complementation (BiFC) for APP dimerization; sAPPβ ELISA; cholesterol-binding mutants of APP\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BiFC dimerization assay with domain mutants and pharmacological intervention, human neuronal model, single lab\",\n      \"pmids\": [\"33296223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FE65 interacts with VLDLR via its PTB1 domain and forms a trimeric complex with APP and VLDLR; this VLDLR–APP interaction alters trafficking and processing of both proteins, and FE65 presence increases the APP–VLDLR interaction in vitro and in vivo.\",\n      \"method\": \"GST pull-down; co-immunoprecipitation in COS7 cells and brain lysates; co-transfection processing assays\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and pulldown from multiple sources confirm interaction and processing effect, but mechanistic detail limited, single lab\",\n      \"pmids\": [\"22429478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"p53 represses APP promoter activity via a mechanism involving DNA sequences downstream of the transcription start site (+55/+101); p53 reduces binding of transcription factor Sp1 to this region (shown by gel shift and ChIP), thereby lowering APP expression.\",\n      \"method\": \"Transient transfection with APP promoter deletion constructs; gel mobility shift assays; chromatin immunoprecipitation; dominant-negative p53; DNA-damaging drug camptothecin\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion mapping, EMSA, and ChIP confirm Sp1 displacement by p53, single lab\",\n      \"pmids\": [\"19049493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"APP expressed on GBM tumor cell surfaces inhibits phagocytosis of tumor-associated macrophages (TAMs) by binding to the CD74/CXCR4 receptor complex; APP binding to CD74 promotes SHP-1 phosphorylation, and disruption of the APP-CD74 axis upregulates TAM phagocytosis in vitro and in vivo.\",\n      \"method\": \"Cell-cell communication analysis; co-immunoprecipitation (APP–CD74/CXCR4); phospho-SHP-1 measurement; phagocytosis assay in vitro and in vivo\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP with functional phagocytosis assay, single lab, limited mechanistic depth in abstract\",\n      \"pmids\": [\"39111632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Rab35 negatively regulates Aβ production by sorting APP and BACE1 out of the endosomal network via distinct effectors: OCRL mediates BACE1 sorting and ACAP2 mediates APP sorting; Rab35 overexpression prevents amyloidogenic trafficking of APP and BACE1 induced by glucocorticoids.\",\n      \"method\": \"Rab35 overexpression/knockdown in neurons; effector (OCRL, ACAP2) perturbation; Aβ ELISA; APP and BACE1 trafficking assays; glucocorticoid treatment model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional perturbation with effector mapping and pharmacological stress model, single lab\",\n      \"pmids\": [\"34876559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Huntingtin (HTT), upon phosphorylation by Akt, regulates anterograde axonal transport of APP; expression of unphosphorylatable HTT decreases axonal transport of APP, reduces presynaptic APP levels, and increases synaptic density. In APPPS1 mice, ablating HTT phosphorylation in vivo reduced presynaptic APP and restored synapse number and memory.\",\n      \"method\": \"Microfluidic corticocortical neuronal network-on-a-chip; live imaging of APP transport; unphosphorylatable HTT knock-in mice crossed to APPPS1; synapse density counts; behavioral testing\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic manipulation (knock-in) with axonal transport imaging, in vivo synapse and behavioral readout, single lab\",\n      \"pmids\": [\"32452382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In Drosophila, overexpression of APP, APLP1, APLP2, and Drosophila APPL induces Notch gain-of-function phenotypes in peripheral nervous system development; genetic analysis identified Numb as a target and implicated Disabled and Neurotactin, placing APP family members in the Notch signaling pathway during neuronal fate determination.\",\n      \"method\": \"Drosophila transgenics; genetic epistasis; appl mutant analysis; cell fate transformation scoring\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis across multiple APP family members with ortholog confirmation, single lab\",\n      \"pmids\": [\"15385958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PKCα mediates PMA-regulated sAPP secretion in human NT2N neurons; long-term PMA treatment causing PKCα downregulation abolished both regulated and constitutive sAPP secretion in NT2N cells, demonstrating that PKCα is the primary isoform coupling PKC activation to alpha-secretase-dependent APP cleavage in neurons.\",\n      \"method\": \"PKC isoform-selective downregulation by prolonged PMA; pharmacological inhibitors (Calphostin C, GF109203X); membrane translocation assays; sAPP ELISA\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific functional loss with processing readout, pharmacological corroboration, single lab\",\n      \"pmids\": [\"10858291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APP and BACE1 come into close proximity intracellularly but not at the cell surface in living cells, as shown by TIRET microscopy; altering cholesterol levels modulates this proximity and APP processing by BACE1, likely via changes in membrane fluidity.\",\n      \"method\": \"Time-resolved FRET combined with total internal reflection microscopy (TIRET) in living cells; sAPP secretion upon cholesterol manipulation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — novel proximity imaging approach but single lab, limited functional validation of mechanism\",\n      \"pmids\": [\"18374657\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APP is a type I transmembrane glycoprotein processed by three competing secretase pathways: β- and γ-secretases sequentially generate Aβ peptides (amyloidogenic pathway), while α-secretase (ADAM9/10/17) cleaves within the Aβ domain to release neuroprotective sAPPα (non-amyloidogenic pathway); APP trafficking through the secretory/endosomal pathway—regulated by phosphorylation at residues including Y682, Y687, and S655, by palmitoylation-driven dimerization, by adaptors FE65/Mint/PAT1a, and by retromer/Rab35-dependent sorting—determines which secretase gains access to APP; AICD released by γ-secretase acts as a transcriptional co-activator (with Fe65, FoxO, and at the WAVE1 and JNK3 loci) to regulate neurogenesis, apoptosis, and feedback inhibition of Aβ production; sAPPα supports dendritic spine maintenance and LTP; and APP interacts at the cell surface with TAG1, Synaptotagmins, BRI2, TrkA, GABA-B receptors, and CD74/CXCR4 to transduce extracellular signals into intracellular responses governing neuronal survival, migration, and synaptic function.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"APP is a type I transmembrane glycoprotein whose proteolytic processing and intracellular trafficking govern neuronal survival, synaptic function, migration, and amyloid-\\u03b2 (A\\u03b2) production [#8, #11]. APP is cleaved along competing pathways: \\u03b1-secretase activity, contributed by ADAM9, ADAM10, and ADAM17 and coupled to neuronal PKC\\u03b1 activation, releases the trophic ectodomain sAPP\\u03b1, which supports dendritic spine density and long-term potentiation [#1, #8, #33], whereas \\u03b2-secretase (BACE1) and \\u03b3-secretase generate A\\u03b2 and the APP-\\u03b2CTF (C99) fragment, the latter raising lysosomal pH and inactivating cathepsin D to drive lysosomal dysfunction [#4]. Which pathway predominates is set by APP trafficking and conformation: phosphorylation at Y687 and S655 directs APP between endocytic and secretory routes [#11, #12], cis-dimerization\\u2014initiated by ER disulfide bonds in the E1 domain and promoted by palmitoylation via DHHC7/DHHC21\\u2014favors BACE1 cleavage [#17, #19], and APP\\u2013BACE1 proximity is modulated by cholesterol binding [#26, #34]. Sorting adaptors and trafficking machinery including PAT1a, retromer (Vps35), and Rab35 (acting through effectors ACAP2 and OCRL) partition APP and BACE1 to limit amyloidogenic processing, while HTT-dependent axonal transport delivers APP to presynaptic terminals [#13, #14, #30, #31]. The \\u03b3-secretase product AICD acts as a transcriptional co-activator: with FE65 it transduces the extracellular ligand TAG1 to suppress neurogenesis, with FoxO it induces the pro-apoptotic gene Bim under oxidative stress, and it directly regulates the WAVE1/Wasf1 and JNK3 loci to control vesicular APP trafficking and neuronal death [#3, #15, #23, #24]. At the cell surface APP engages partners including TAG1, Synaptotagmins, BRI2, TrkA, and the CD74/CXCR4 complex to couple extracellular signals to processing, survival, and\\u2014in glioblastoma\\u2014inhibition of macrophage phagocytosis [#3, #5, #9, #18, #29]. APP expression is further tuned post-transcriptionally by the mRNA-binding proteins hnRNP C and HuD and transcriptionally by an ApoE-driven DLK\\u2192MKK7\\u2192ERK\\u2192AP-1 cascade and p53/Sp1 promoter regulation [#6, #10, #21, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that APP abundance is controlled post-transcriptionally, identifying hnRNP C as a stabilizing 3'-UTR binder long before APP's many regulatory inputs were mapped.\",\n      \"evidence\": \"In vitro reticulocyte lysate translation with cis-element mutagenesis and RNA gel shift\",\n      \"pmids\": [\"9649628\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether hnRNP C regulates APP in neurons in vivo not addressed\", \"Does not link expression level to A\\u03b2 output\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined PKC\\u03b1 as the kinase isoform coupling PKC activation to regulated sAPP (\\u03b1-secretase) secretion in neurons, connecting signaling to the non-amyloidogenic pathway.\",\n      \"evidence\": \"Isoform-selective PKC downregulation and pharmacological inhibition in human NT2N neurons with sAPP ELISA\",\n      \"pmids\": [\"10858291\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphorylation target of PKC\\u03b1 on APP/secretase not identified\", \"Mechanism linking PKC\\u03b1 to ADAM activity unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed APP, with FE65, localizes to motility structures and accelerates cell migration, establishing a non-amyloid cell-biological role at focal complexes.\",\n      \"evidence\": \"Immunofluorescence co-localization and MDCK wound-healing migration assay with co-expression\",\n      \"pmids\": [\"11425871\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of migration enhancement (integrin signaling vs surface level) unclear\", \"Relevance to neuronal migration in vivo not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Tested whether caspase cleavage of the APP tail drives amyloidogenesis, finding it instead removes the endocytosis signal and reduces A\\u03b2\\u2014a negative result constraining apoptosis-amyloid models.\",\n      \"evidence\": \"Caspase-site-masked APP mutants and serum-withdrawal caspase activation with internalization and A\\u03b2 readouts\",\n      \"pmids\": [\"11397796\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of caspase-cleaved APP fragment undefined\", \"Single-cell-line context\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified ADAM9/10/17 as the collective endogenous \\u03b1-secretase, defining the enzymatic basis of the non-amyloidogenic cleavage.\",\n      \"evidence\": \"Overexpression in COS-7 and dsRNA knockdown of each ADAM in A172 cells measuring \\u03b1-secretase activity\",\n      \"pmids\": [\"12535668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of each ADAM in neurons not resolved\", \"Regulation of ADAM access to APP not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Linked neuronal activity to A\\u03b2 production and demonstrated A\\u03b2 depresses excitatory transmission via NMDA receptors, proposing an activity-dependent negative-feedback role.\",\n      \"evidence\": \"Hippocampal slice electrophysiology with APP overexpression and NMDA receptor blockade\",\n      \"pmids\": [\"12670422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular coupling of activity to secretase access undefined\", \"Physiological vs pathological A\\u03b2 concentrations not delineated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected APP to neuronal apoptosis through APP-BP1 binding the C31 tail and a NEDD8-conjugation requirement, implicating ubiquitin-like signaling in APP-induced death.\",\n      \"evidence\": \"Co-IP, lipid raft fractionation, dominant-negative hUbc12, and neuronal apoptosis assay\",\n      \"pmids\": [\"14557245\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NEDD8 substrate driving apoptosis not identified\", \"Relationship to AICD-dependent death pathways unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed APP family members in Notch signaling during neuronal fate determination via Numb, expanding APP function into developmental cell-fate control.\",\n      \"evidence\": \"Drosophila transgenics and genetic epistasis across APP/APLP1/APLP2/APPL\",\n      \"pmids\": [\"15385958\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical link between APP and Notch components missing\", \"Conservation in mammalian neurogenesis untested here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified BRI2 as a cis-membrane transmembrane partner that shifts APP toward \\u03b2-cleavage, an early example of a membrane partner steering processing.\",\n      \"evidence\": \"Reciprocal co-IP with transmembrane-domain deletion mapping and processing-product measurement\",\n      \"pmids\": [\"16027166\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo neuronal relevance of BRI2-APP processing effect not shown\", \"Mechanism by which complex favors BACE1 access unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined PAT1a as a TGN/endosomal adaptor binding APP's basolateral sorting signal and controlling surface levels and A\\u03b2 output, mechanistically linking sorting to processing.\",\n      \"evidence\": \"In vivo co-IP, primary neuron co-localization, bidirectional RNAi/overexpression with surface and A\\u03b2 readouts\",\n      \"pmids\": [\"17050537\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of sorting-signal recognition undefined\", \"Interplay with other adaptors not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated that Tyr687 phosphorylation status dictates APP endocytosis and choice of processing pathway, establishing a PTM switch for amyloidogenesis.\",\n      \"evidence\": \"Y687E/Y687F phosphomutant APP-GFP with live imaging, transferrin co-localization, and A\\u03b2 ELISA\",\n      \"pmids\": [\"17873282\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase/phosphatase controlling Y687 not identified\", \"In vivo significance not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified TAG1 as an extracellular ligand triggering \\u03b3-secretase/AICD release and Fe65-dependent suppression of neurogenesis, defining a receptor-like signaling axis for APP.\",\n      \"evidence\": \"Co-IP, genetic epistasis across TAG1/APP/Fe65 knockouts, and AICD-domain-mutant rescue in neural precursors\",\n      \"pmids\": [\"18278038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TAG1-APP binding undefined\", \"Generalization beyond neurogenesis not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Localized APP-BACE1 encounter to intracellular compartments rather than the cell surface and showed cholesterol modulates this proximity.\",\n      \"evidence\": \"Time-resolved FRET with TIRF microscopy in living cells plus cholesterol manipulation and sAPP readout\",\n      \"pmids\": [\"18374657\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single-lab proximity imaging with limited functional validation\", \"Specific compartment not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established PKC-mediated S655 phosphorylation as a positive regulator of APP secretory exit from the Golgi favoring \\u03b1-cleavage, complementing the Y687 switch.\",\n      \"evidence\": \"S655 phosphomimetic APP695-GFP mutants with Golgi dynamics imaging and sAPP quantification\",\n      \"pmids\": [\"19381782\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct kinase identity and link to PKC\\u03b1 not established\", \"In vivo effect on A\\u03b2 not measured\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed p53 represses the APP promoter by displacing Sp1, linking the DNA-damage response to APP transcription.\",\n      \"evidence\": \"Promoter deletion constructs, EMSA, ChIP, dominant-negative p53, and camptothecin treatment\",\n      \"pmids\": [\"19049493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neuronal/in vivo relevance not tested\", \"Physiological trigger for p53 control of APP unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined sAPP\\u03b1 as the mediator of APP's trophic role at synapses, with APP knockout reducing spine density, arborization, and LTP and sAPP\\u03b1 rescuing spines.\",\n      \"evidence\": \"APP knockout mouse, hippocampal culture, in vivo spine counting, LTP electrophysiology, and sAPP\\u03b1 rescue\",\n      \"pmids\": [\"22884903\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"sAPP\\u03b1 receptor mediating spine maintenance not identified\", \"Partial rescue implies additional APP-dependent factors\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked APP to NGF/TrkA neurotrophic signaling, showing TrkA phosphorylates APP at Y682 and APP reciprocally regulates TrkA distribution and NGF sensitivity.\",\n      \"evidence\": \"Co-IP, phosphospecific antibodies, and Y682 knock-in mice with neurotrophic survival assays\",\n      \"pmids\": [\"21849536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Y682 and Y687 events are coupled not resolved\", \"Downstream survival effectors not mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed APP dimerization is initiated in the ER via E1-domain disulfide bonds and modulated by the KPI domain, establishing the structural origin of dimer-dependent processing.\",\n      \"evidence\": \"Organelle-retention constructs, non-reducing SDS-PAGE, E1 deletion mutants, and split-GFP in CHO-K1\",\n      \"pmids\": [\"22105709\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of ER dimerization for A\\u03b2 not directly tested here\", \"Isoform-specific dimerization in neurons not shown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Implicated retromer in limiting amyloidogenic processing, with Vps35 loss raising A\\u03b242:A\\u03b240 and APP CTFs in exosomes.\",\n      \"evidence\": \"siRNA knockdown of Vps35 in HEK-293/APP695 with A\\u03b2 ELISA and exosome Western blot\",\n      \"pmids\": [\"21515373\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single-gene knockdown, single method per endpoint\", \"Neuronal/in vivo confirmation lacking\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified a FE65-bridged APP\\u2013VLDLR trimeric complex altering trafficking and processing of both proteins.\",\n      \"evidence\": \"GST pull-down and co-IP in COS7 and brain lysates with processing assays\",\n      \"pmids\": [\"22429478\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Limited mechanistic detail and single-lab data\", \"Functional consequence for A\\u03b2 in vivo unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established AICD as a FoxO co-activator that induces pro-apoptotic Bim under oxidative stress, defining a transcriptional route for APP-induced cell death.\",\n      \"evidence\": \"Drosophila genetic screen, AICD-FoxO co-IP, nuclear fractionation, and Bim luciferase reporter\",\n      \"pmids\": [\"24832605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution vs Fe65-dependent AICD targets unclear\", \"Stress threshold for nuclear translocation undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed HuD post-transcriptionally stabilizes both APP and BACE1 mRNAs, coordinately raising A\\u03b2 in vivo.\",\n      \"evidence\": \"RNA immunoprecipitation, mRNA half-life measurement, and HuD-overexpressing transgenic mice\",\n      \"pmids\": [\"24857657\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream control of HuD activity not addressed\", \"Direct vs indirect BACE1 effect on A\\u03b2 not separated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that C99 multimerization impedes \\u03b3-secretase cleavage and that primary sequence sets processivity independent of dimerization, refining how A\\u03b2 length is determined.\",\n      \"evidence\": \"Recombinant C100 substrates with isolated multimeric forms in in vitro \\u03b3-secretase assays\",\n      \"pmids\": [\"25350374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular regulation of C99 multimer state unknown\", \"Link to dimerization machinery (palmitoylation) not bridged here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified DISC1 as a direct APP partner controlling surface expression and internalization, shifting processing toward \\u03b1-cleavage.\",\n      \"evidence\": \"RNAi in cortical neurons, co-IP, surface biotinylation, and APP-binding-domain-deletion rescue\",\n      \"pmids\": [\"25224257\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trafficking step targeted by DISC1 not pinpointed\", \"In vivo relevance to A\\u03b2 not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a reciprocal AICD\\u2013WAVE1 circuit: AICD represses Wasf1 transcription while WAVE1 promotes APP vesicle budding and surface levels, with WAVE1 reduction rescuing AD-model memory.\",\n      \"evidence\": \"ChIP, co-IP, vesicle budding assay, A\\u03b2 ELISA, and in vivo Wasf1 reduction with behavior\",\n      \"pmids\": [\"26280122\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the feedback loop is engaged under physiological conditions unclear\", \"Spatial coordination of budding step undefined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified Synaptotagmins (Syt-1/2/9) as in vivo APP partners binding the E1-KPI linker and modulating BACE1-mediated A\\u03b2 generation.\",\n      \"evidence\": \"Brain affinity-purification MS, in vivo co-IP, GST domain mapping, and bidirectional Syt perturbation with A\\u03b2 ELISA\",\n      \"pmids\": [\"26202512\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Syt promotes BACE1 access unresolved\", \"Link to synaptic vesicle cycle vs processing not separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected APP palmitoylation to dimer formation and \\u03b2-cleavage, with DHHC7/DHHC21 driving palmitoylated dimers in detergent-resistant membranes preferred by BACE1.\",\n      \"evidence\": \"FLIM/FRET, co-IP, DHHC7/21 overexpression, palmitoylation inhibitors, and in vitro BACE1 assay on palAPP\",\n      \"pmids\": [\"27875558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance of palmitoylation-driven amyloidogenesis untested\", \"Depalmitoylation enzymes not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined an ApoE-driven DLK\\u2192MKK7\\u2192ERK\\u2192AP-1 cascade that transcriptionally upregulates APP and A\\u03b2 with ApoE4>E3>E2 potency, linking the major AD risk gene to APP expression.\",\n      \"evidence\": \"ES-cell-derived human neurons co-cultured with glia, kinase inhibitors, reporter assays, and in vivo mouse validation\",\n      \"pmids\": [\"28111074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ApoE receptor initiating the cascade not pinpointed\", \"Contribution relative to ApoE effects on A\\u03b2 clearance not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed AICD transcriptionally upregulates JNK3 to promote axotomy-induced retinal ganglion cell death, extending AICD's neuronal death program to a defined locus.\",\n      \"evidence\": \"Optic nerve axotomy, ChIP and luciferase at JNK3 locus, APP knockout, and \\u03b3-secretase inhibitor with RGC survival counts\",\n      \"pmids\": [\"29238071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether JNK3 induction requires Fe65 not addressed\", \"Relevance to A\\u03b2-driven degeneration unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified APP-\\u03b2CTF (C99) rather than A\\u03b2 as the driver of lysosomal dysfunction in Down syndrome by alkalinizing lysosomes and inactivating cathepsin D.\",\n      \"evidence\": \"DS fibroblasts and Ts2 neurons, direct lysosomal pH measurement, APP siRNA, BACE1 inhibition, and in vivo Bace1 deletion\",\n      \"pmids\": [\"31043483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which C99 raises lysosomal pH undefined\", \"Generalization beyond DS/trisomy context not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed statins reduce BACE1 processing by enhancing cholesterol-binding-dependent APP dimerization and reducing APP-BACE1 proximity, linking lipid pharmacology to processing geometry.\",\n      \"evidence\": \"iPSC-derived neurons, BiFC dimerization, sAPP\\u03b2 ELISA, and APP cholesterol-binding mutants\",\n      \"pmids\": [\"33296223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation with palmitoylation-driven dimer favoring \\u03b2-cleavage unresolved\", \"In vivo amyloid effect of statins not shown here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated HTT phosphorylation by Akt drives anterograde axonal transport of APP, controlling presynaptic APP and synapse number in AD models.\",\n      \"evidence\": \"Microfluidic neuron-on-a-chip live imaging and unphosphorylatable HTT knock-in crossed to APPPS1 with synapse and behavior readouts\",\n      \"pmids\": [\"32452382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Motor adaptors linking phospho-HTT to APP cargo not identified\", \"Effect on A\\u03b2 load vs synapse number not separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined Rab35 as a negative regulator of A\\u03b2 that sorts APP and BACE1 out of endosomes via distinct effectors ACAP2 and OCRL, countering stress-induced amyloidogenic trafficking.\",\n      \"evidence\": \"Rab35 perturbation, effector (OCRL/ACAP2) manipulation, glucocorticoid model, and trafficking/A\\u03b2 readouts in neurons\",\n      \"pmids\": [\"34876559\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Coordination with retromer-dependent sorting unclear\", \"Upstream control of Rab35 activity undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a non-neuronal immune role: surface APP on glioblastoma binds CD74/CXCR4 and phosphorylates SHP-1 to suppress tumor-associated macrophage phagocytosis.\",\n      \"evidence\": \"Cell-cell communication analysis, APP-CD74/CXCR4 co-IP, phospho-SHP-1, and phagocytosis assays in vitro and in vivo\",\n      \"pmids\": [\"39111632\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single co-IP with limited mechanistic depth\", \"Whether full-length APP or a fragment is the ligand unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many converging trafficking adaptors, PTMs, dimerization states, and partner interactions are integrated in a single neuron to set the balance between trophic sAPP\\u03b1 signaling and amyloidogenic A\\u03b2/C99 output remains unresolved.\",\n      \"evidence\": \"No single study reconciles the competing dimerization (palmitoylation vs cholesterol/statin), sorting (retromer/Rab35/PAT1a), and PTM (Y682/Y687/S655/acetylation) mechanisms into one quantitative model\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model of processing-pathway choice\", \"Receptor(s) for sAPP\\u03b1 trophic signaling unidentified\", \"Physiological vs pathological thresholds for AICD transcriptional programs undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 15, 23, 24]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 9, 29]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 16, 18, 29, 34]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [12, 13, 15]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [13, 14, 30]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 23, 24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 21, 30]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [15, 23, 24, 28]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 5, 18, 20]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [13, 14, 30, 31]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 9, 21]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [7, 23, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FE65\", \"TAG1\", \"BRI2\", \"TrkA\", \"DISC1\", \"VLDLR\", \"BACE1\", \"CD74\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}